PMID: 9635523Jul 11, 1998Paper

A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma

Cancer
P M Sanz-AltamiraK E Stuart

Abstract

Unresectable adenocarcinoma of the biliary tree are associated with a very poor prognosis. 5-fluorouracil (5-FU) combination regimens have produced objective response rates in approximately 10-20% of patients. Leucovorin increases the selective cytotoxicity of 5-FU. There also are encouraging reports of carboplatin in combination with 5-FU in other gastrointestinal tract malignancies. Fourteen consecutive eligible patients were treated with a combination of carboplatin, 300 mg/m2, intravenously (i.v.) on Day 1 only and 5-FU, 400 mg/m2, i.v. with leucovorin, 25 mg/m2, i.v. on Days 1-4. All patients were required to have a histologically confirmed diagnosis and measurable disease. Patients were evaluated for response, survival, and toxicity. A total of 48 cycles of therapy were delivered. The median survival was 5 months. One patient achieved complete remission and two others partial remission, for a total response rate of 21.4%. Four additional patients had stable disease for a median duration of 4 months. The therapy was well tolerated, with moderate myelosuppression as the main dose-limiting toxicity. The current combination regimen of leucovorin-modulated 5-FU with carboplatin is well tolerated with appropriate supportive car...Continue Reading

Citations

Feb 16, 2008·Journal of Hepato-biliary-pancreatic Surgery·Junji FuruseUNKNOWN Japan Society of Clinical Oncology
Oct 1, 2008·International Journal of Medical Sciences·Matthew KaufmanAdrienne Thomas
Nov 15, 2008·World Journal of Gastroenterology : WJG·Jian Yang, Lu-Nan Yan
Jul 24, 2010·World Journal of Gastroenterology : WJG·Naohiko KohyaKohji Miyazaki
Oct 28, 1999·The New England Journal of Medicine·P C de GroenD M Nagorney
Jun 22, 2013·Critical Reviews in Oncology/hematology·Stefano CeredaMichele Reni
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F BerrJ Mössner
Oct 3, 2012·Surgical Oncology·C BoutrosP Somasundar
Mar 11, 2005·Journal of Vascular and Interventional Radiology : JVIR·Ingrid BurgerJean-Francois H Geschwind
May 25, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Aaron J QuynIain S Tait
Apr 29, 2008·Chinese Medical Sciences Journal = Chung-kuo I Hsüeh K'o Hsüeh Tsa Chih·Xiao-ran He, Xiao-peng Wu
Mar 25, 2009·Surgical Oncology Clinics of North America·Fidel David Huitzil-MelendezGhassan K Abou-Alfa
Aug 19, 2007·Current Problems in Surgery·Sean P ClearySteven Gallinger
Dec 14, 2006·Critical Reviews in Oncology/hematology·Melanie B Thomas
May 13, 2015·Best Practice & Research. Clinical Gastroenterology·N Schweitzer, A Vogel
Jun 10, 2006·Cancer Treatment Reviews·Rossana BerardiCascinu Stefano
Jul 16, 2005·Surgical Oncology·D SinghalD J Gouma
Jul 20, 2012·Critical Reviews in Oncology/hematology·Donatella MarinoMassimo Aglietta
Oct 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S MezawaY Niitsu
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer J KnoxMalcolm J Moore
Mar 11, 2017·Expert Opinion on Therapeutic Targets·Jennifer YangGregory B Lesinski
Jun 7, 2007·American Journal of Clinical Oncology·Jürgen FeisthammelMarcus Wiedmann
Dec 3, 2008·European Journal of Gastroenterology & Hepatology·Amir Said Alizadeh NaderiWilliam Martens Lee
Jun 7, 2006·American Journal of Clinical Oncology·Jeong Youp ParkSi Young Song
Mar 7, 2002·Current Treatment Options in Gastroenterology·Valerie Byrnes, Nezam Afdhal
Sep 6, 2005·Cancer Chemotherapy and Pharmacology·Takuji OkusakaToshio Tsuyuguchi
Aug 8, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Geng ZhiminRajiv Kumar Jha
Dec 17, 2010·World Journal of Hepatology·Zenichi MoriseChinatsu Takeura
Feb 3, 2004·The Oncologist·Christopher D AndersonRavi S Chari
Jun 26, 2014·Langenbeck's Archives of Surgery·Matthew J WeissTimothy M Pawlik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.